Vogenx Completes Enrollment of Phase 2 Trial of Mizagliflozin for Post-Bariatric Hypoglycemia
DURHAM, NC / ACCESSWIRE / February 15, 2024 / Vogenx, Inc., a clinical-stage developer of novel therapeutics for the treatment...
Month: February 2024
NanoViricides Has Filed its Quarterly Report – NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum...
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater...
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
Carlsbad, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on...
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will...
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
Designation Based on Pre-Clinical Data and Initial Clinical Data from the Company's MAvERIC-Pilot Phase II StudyThis is a Designated News...
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
LONDON, UK / ACCESSWIRE / February 15, 2024 / Poolbeg Pharma (AIM:POLB, OTCQB:POLBF, "Poolbeg" or the "Company"), a biopharmaceutical company...
Senzime: Year-end Report January – December 2023
UPPSALA, SWEDEN / ACCESSWIRE / February 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, February 15, 2024. Senzime AB (publ):s...
GE HealthCare Management to Present at Upcoming Investor Conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), is announcing today that its Vice President and Chief Financial Officer, Jay Saccaro, will be...
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
Conference Call Scheduled for Thursday, February 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite...
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
Q2 2024 operating income of $2.4 millionQ2 2024 net loss of $0.2 million and adjusted EBITDA1 of $5.1 millionQ2 2024...
ESO Appoints Joy Brown to Board of Directors
Accomplished executive brings 20+ years of experience leading transformative data intelligence initiatives across industries.AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading data and...
AGFA HealthCare Welcomes RedSalud Chile to Its Enterprise Imaging Network
MORTSEL, BELGIUM / ACCESSWIRE / February 14, 2024 / In our unwavering commitment to providing cutting-edge clinical technology in Latin...
HistoSonics Awarded Key Position in UK’s Novel Innovation Program
Edison Histotripsy System Selected for Competitive Accelerated Market Access ProgramMINNEAPOLIS--(BUSINESS WIRE)--#HistoSonics--HistoSonics®, (www.histosonics.com), the manufacturer of the Edison® System and novel...
Alexander Group to Speak and Exhibit at HIMSS Global Conference and Exhibition
Tray Chamberlin, Principal and Digital Health Practice Lead, to spearhead conference session on The Evolving Commercial Models of Digital HealthSCOTTSDALE,...
Allure Esthetic Plastic Surgery’s Dr. Javad Sajan Elevates New, Advanced Method of Breast Augmentation
Transumbilical Breast Augmentation Technique (TUBA) Reduces Risk of Breast Implant Complications and ReactionsSEATTLE, WA / ACCESSWIRE / February 14, 2024...
Rare Element Resources Announces Commencement of Rights Offering of Common Shares
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce that today it has...
Rare Element Resources Announces Commencement of Rights Offering of Common Shares
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to announce that today it has...
ModMed ranks #1 in all 11 of its specialty-specific EHR systems in 2024 Black Book Survey
Health IT company takes home top rankings for specialty-specific EHRs in allergy and OBGYN for the first timeBOCA RATON, Fla.--(BUSINESS...